If this is really how the intervention took place, serious questions need to be addressed in parliament in regard to such obstruction, not to mention the filibustering that frequently accompanies the tactic:
Tom
As I have mentioned before, one medicine I know of now costs around £253 for 28 tablets - whereas in Greece the same medicine (different make) costs about 1.2 euros, and even in Germany another different make is around 30 euros for 100 tablets.
If I need that medicine and am expected to make a co-payment, is there any reasonable basis for expecting a huge dollop simply because the NHS has repeatedly proved itself unable to procure efficiently and cost-effectively?
Even if the co-payment is limited as a percentage of cost, as a cap on maximum amount, thus perhaps never being more than £10 or whatever, why should I ever actually be asked for more than the cost that the NHS could achieve, if it had the will and political drive?
Further, for this and other related medicines, changes of make should be checked by repeated blood tests because the medicines are not bio-equivalent. Where is the fairness of people possibly having to make co-payments simply because the NHS is unable and/or unwilling to ensure continued receipt of the same make, month after month?
Finally, what if the cost of charging co-payments actually ends up higher than the amount brought in? The only likely upshot of that would to be increase the co-payments from what might appear justifiable to an inflated amount down to the bureaucracy involved.
In years to come, the first call on people's estates will be the cost of their PM. :